Low-value practices in oncology contributing to financial toxicity

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

5 Jul 2017

The past and future of breast cancer treatment—from the papyrus to individualise...

Dr Felipe Ades - Hospital Israelita Albert Einstein, Morumbi, São Paulo

5 Jul 2017

(1/6) ASCO 2017: Introduction to Expert discussion on the latest in prostate can...

Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James

12 Jun 2017

(2/6) ASCO 2017: LATITUDE data

Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James

12 Jun 2017

(3/6) ASCO 2017: STAMPEDE data

Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James

12 Jun 2017

(4/6) ASCO 2017: Expert discussion on the latest in prostate cancer

Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James

12 Jun 2017

(5/6) ASCO 2017: ASCO highlights in prostate cancer

Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James

12 Jun 2017

(6/6) ASCO 2017: Round up of expert discussion on the latest in prostate cancer

Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James

12 Jun 2017

Clinical potential of trastuzumab biosimilar CTP6

Prof Francisco Esteva - NYU Langone Medical Center, New York, USA

8 Jun 2017

ASCO 2017: Round up

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

6 Jun 2017

Updates in melanoma: Treating BRAF and brain metastases

Prof Georgina Long - University of Sydney, Sydney, Australia

5 Jun 2017

Bendamustine for indolent lymphoma reduces relapse after 10 years

Dr Mathias Rummel - University of Giessen, Giessen, Germany

5 Jun 2017

ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year

Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy

5 Jun 2017

T-VEC and checkpoint therapy for melanoma

Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA

5 Jun 2017

Prevalence of homologous recombination deficiency among 53,000 tumour samples

Dr Arielle Heeke - Georgetown Lombardi Comprehensive Cancer Center, Washington, ...

5 Jun 2017

Natural plant based balm antidote to severe nail toxicity during chemotherapy

Dr Robert Thomas - Cambridge University Hospitals, Cambridge, UK

5 Jun 2017

Dacomitinib for EGFR positive lung cancer

Dr Tony Mok, The Chinese University of Hong Kong, Shatin, China

5 Jun 2017

New ALK inhibitor alectinib halts lung cancer growth more than a year longer tha...

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA

5 Jun 2017

ASCO 2017: Expert discussion on the latest in prostate cancer

Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James

5 Jun 2017

ASCO 2017: Following the practice changing results from STAMPEDE

Dr Neal Shore and Prof Nicholas James

5 Jun 2017

Treating advanced melanoma with ipilimumab and HF10

Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA

5 Jun 2017

Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers

Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA

5 Jun 2017

Immunotherapy may slow the growth of malignant pleural mesothelioma

Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France

5 Jun 2017

Immunotherapy for mesothelioma could be on the horizon

Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France

5 Jun 2017

CAR T-cell therapy can be used to send multiple myeloma into lasting remission

Dr Wanhong Zhao - Xi’an Jiaotong University Hospital, China

5 Jun 2017

Alectinib eclipses crizotinib for ALK positive lung cancer

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA

5 Jun 2017

Adding a second HER2 targeted medicine may lower chance of invasive breast cance...

Dr Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany

5 Jun 2017

Targeted sequencing in endocrine refractory breast cancer

Dr John Bartlett - Ontario Institute for Cancer Research, Toronto, Canada

5 Jun 2017

Results from the APHINITY trial of two HER2 targeted agents with chemo

Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany

5 Jun 2017

Treating BRCA breast cancer with PARP inhibition

Dr Mika Sovak - AstraZeneca, Cambridge, UK

4 Jun 2017

Relieving spinal cord compression symptoms with a single radiation treatment

Prof Peter Hoskin - Mount Vernon Cancer Centre, Northwood, United Kingdom

4 Jun 2017

Implementing new health initiatives in low-resource environments

Prof Sana Al Sakhun - Jordanian Oncology Society, Jordan

4 Jun 2017

Halving duration of ADT for high risk prostate cancer patients

Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada

4 Jun 2017

New personalised therapies for lung cancer

Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA

4 Jun 2017

Findings of a phase I/II study of nivolumab in patients with virus-associated tu...

Dr Antoine Hollebecque - Institut Gustave Roussy, Paris, France

4 Jun 2017

Nivolumab and ipilimumab for metastatic sarcoma

Dr Sandra D'Angelo - Memorial Sloan Kettering Cancer Center, New York, USA

4 Jun 2017

Selumetinib in children with recurrent or refractory low-grade glioma

Dr Jason Fangusaro - Ann & Robert H. Lurie Children's Hospital of Chicago, Chica...

4 Jun 2017

Dose escalation results of ceritinib and nivolumab for ALK NSCLC

Dr Enriqueta Felip - Vall d’Hebron University Hospital, Barcelona, Spain

4 Jun 2017

Phase III results of olaparib for BRCA breast cancer

Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA

4 Jun 2017

Global health initiative oncology

Prof Ophira Ginsburg - NYU Langone Medical Center, New York, USA

4 Jun 2017

Self-reporting symptoms online improves patient care, chemotherapy duration and ...

Prof Ethan Basch - Lineberger Comprehensive Cancer Centre of the University of N...

4 Jun 2017

Tivantinib as second line therapy for high-MET HCC

Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy

4 Jun 2017

9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy

Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy

4 Jun 2017

Expert prostate discussion: Clinical diagnostics, genomics, systemic and radiolo...

Dr Chris Parker and Prof Charles Ryan

4 Jun 2017

Web-based system for self-reporting symptoms may help patients live longer

Prof Ethan Basch - Lineberger Comprehensive Cancer Centre of the University of N...

4 Jun 2017

Olaparib slows growth of BRCA-related metastatic breast cancer

Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA

4 Jun 2017

Global study sets new risk-based standard to personalise chemotherapy for colon ...

Dr Axel Grothey - Mayo Clinic Cancer Centre, Rochester, USA

4 Jun 2017

3 or 6 months adjuvant oxaliplatin for colorectal cancer

Dr Tim Iveson - University Hospital Southampton, Salisbury, UK

4 Jun 2017

No link between pregnancy and breast cancer relapse

Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium

4 Jun 2017

Cancer and caring in modern medicine

Prof Siddhartha Mukherjee - Columbia University Medical Center, New York, USA

4 Jun 2017

Pooled analysis of avelumab for metastatic urothelial carcinoma

Dr Andrea Apolo - National Cancer Institute, Bethesda, USA

3 Jun 2017

Cancer and living meaningfully: the CALM intervention

Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada

3 Jun 2017

'Conquer Fear' of disease recurrence

Dr Jane Beith - University of Sydney, Sydney, Australia

3 Jun 2017

Screening for 508 genes in liquid biopsy to chart cancer evolution

Dr Pedram Razavi - Memorial Sloan Kettering Cancer Centre, New York, USA

3 Jun 2017

Larotrectinib shows durable efficacy across diverse paediatric and adult cancers

Dr David Hyman - Memorial Sloan Kettering Cancer Centre, New York, USA

3 Jun 2017

Routine genomic testing is feasible, but only a subset of patients benefit

Dr Olivier Trédan - Centre Léon Bérard, Lyon, France

3 Jun 2017

Molecular profiles and the future of adjuvant therapy

Dr Rodrigo Dienstmann - Vall d’Hebron Institute of Oncology, Barcelona, Spain

3 Jun 2017

Pregnancy after breast cancer no associated with relapse risk

Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium

3 Jun 2017

Delaying metastatic prostate cancer, improving survival with abiraterone

Prof Karim Fizazi - Institut Gustave Roussy, Paris, France

3 Jun 2017

STAMPEDE trial: abiraterone for advanced prostate cancer reduces progression/dea...

Prof Nick James - Queen Elizabeth Hospital Birmingham & University of Birmingham...

3 Jun 2017

Hypogonadism following cisplatin treatment of testicular cancer

Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine, Indianapolis...

2 Jun 2017

Recent childhood cancer survivors face less chronic disease risk than previous d...

Dr Todd Gibson - St Jude Children's Research Hospital, Memphis, USA

2 Jun 2017

Steady decrease in severe health problems for childhood cancer survivors

Dr Todd M. Gibson - St Jude Children's Research Hospital, Memphis, USA

2 Jun 2017

Low testosterone after testicular cancer could be linked to chronic health probl...

Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine, Indianapolis...

2 Jun 2017

Single radiation treatment can sufficiently relieve spinal cord compression symp...

Prof Peter Hoskin - Mount Vernon Cancer Centre, Northwood, United Kingdom

2 Jun 2017

Web-based remote therapy program improves quality of life and lowers distress af...

Dr Viviane Hess - University Hospital of Basel, Basel, Switzerland

2 Jun 2017

Easing distress in patients with cognitive therapy

Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada

2 Jun 2017

Psychological intervention lowers fear of cancer recurrence

Dr Jane Beith - University of Sydney, Australia

2 Jun 2017